Johnson & Johnson Announces Retirement of Executive Vice President Jennifer Taubert and Appointment of Tom Cavanaugh

Details

Taubert, who has been with the company for over 21 years, will be succeeded by Tom Cavanaugh, currently the Company Group Chairman, North America, Innovative Medicine. Cavanaugh brings nearly three decades of biopharmaceutical experience and leadership to the role.

Items reported

About Johnson & Johnson

Johnson & Johnson is a multinational corporation engaged in the research, development, production, and sale of a broad range of healthcare products. Primarily known for its pharmaceuticals, medical devices, and consumer health products, Johnson & Johnson has a significant presence in the global healthcare industry. It develops medications for a variety of fields such as immunology, oncology, neurology, infectious diseases, and vaccines. The company also produces a wide array of medical devices for surgery, orthopedics, and cardiovascular health. In addition to pharmaceuticals, Johnson & Johnson is renowned for its consumer health products, including baby care, skin and hair care, wound care, and over-the-counter pharmaceuticals, with well-recognized brands like Band-Aid, Tylenol, and Neutrogena. Operating globally, the corporation's extensive portfolio and commitment to healthcare innovation make it a pivotal player in the industry, ensuring it remains influential in addressing worldwide health challenges and advancing medical technology.